HIV in Africa (Communication arising): chemokine-receptor genes and AIDS risk. by Ramaley, P, French, N, Kaleebu, P, Gilks, C, Whitworth, J, Hill, A

HIV in Africa - Chemokine-receptor genes and AIDS risk by Ramaley, P, French, N, Kaleebu, P, Gilks, C, Whitworth, J, Hill, A

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda by Kaleebu P, Todd J, Miiro G, Pala P, Kyosiimire-Lugemwa J, Imami N, Gotch F

P20-10. Differences in patterns of Gag-induced immunogenetic pressure occur between clades A and D chronic HIV-1 infection in a Ugandan population by Lyagoba F, Auma B, Pala P, Pimego E, Mugaba S, Nanteza B, Ndembi N, Serwanga J, Kaleebu P

Pilot study of antibodies against varicella zoster virus and human immunodeficiency virus in relation to the risk of developing stroke, nested within a rural cohort in Uganda by Asiki, G, Stockdale, L, Kasamba, I, Vudriko, T, Tumwekwase, G, Johnston, T, Kaleebu, P, Kamali, A, Seeley, J, Newton, R

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy. by Serwanga, J, Mugaba, S, Betty, A, Pimego, E, Walker, A, Munderi, P, Gilks, C, Gotch, F, Grosskurth, H, Kaleebu, P

The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. by Elliott, A, Hurst, T, Balyeku, M, Quigley, M, Kaleebu, P, French, N, Biryahwaho, B, Whitworth, J, Dockrell, H, Hayes, R

HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosis. by Hodsdon, W, Luzze, H, Hurst, T, Quigley, M, Kyosiimire, J, Namujju, P, Johnson, J, Kaleebu, P, Okwera, A, Elliott, A

Ebola disease: bridging scientific discoveries and clinical application by Rojek, A, Fieggen, J, Apiyo, P, Caluwaerts, S, Fowler, RA, Kaleebu, P, Kojan, R, Lado, M, Lambe, T, Dunning, J, Horby, P

Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda by Anywaine, Z, Hansen, C, Warimwe, GM, Abu-Baker Mustapher, G, Nyakarahuka, L, Balinandi, S, Ario, AR, Lutwama, JJ, Elliott, A, Kaleebu, P

Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis by Kitonsa, J, Kiwanuka, J, Anywaine, Z, Kansiime, S, Katumba, K, Aeron, N, Beardsley, J, Kibengo, F, Gray, A, Kaleebu, P, Day, J

A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease. by Cooke, G, Tosh, K, Ramaley, P, Kaleebu, P, Zhuang, J, Nakiyingi, J, Watera, C, Gilks, C, French, N, Whitworth, J, Hill, A

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the... by Kityo, C, Gibb, D, Gilks, C, Goodall, R, Mambule, I, Kaleebu, P, Pillay, D, Kasirye, R, Mugyenyi, P, Walker, A, Dunn, D

CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans. by Stanton, T, Boxall, S, Bennett, A, Kaleebu, P, Watera, C, Whitworth, J, French, N, Dawes, R, Hill, A, Bodmer, W, Beverley, P, Tchilian, E

Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uga... by Kitonsa, J, Nsubuga, R, Mayanja, Y, Kiwanuka, J, Nikweri, Y, Onyango, M, Anywaine, Z, Ggayi, A-B, Kibengo, FM, Kaleebu, P, Day, J

Interferon-gamma Responses to HIV-1 Clade A and D Peptides in Ugandan Serodiscordant Couples - the CHAVI 002 Protocol by Pala, P, Pimego, E, Senkaali, D, Auma, B, Mugaba, S, Nakiboneka, R, Serwanga, J, Watera, C, Goonetilleke, N, Haynes, B, Mcmichael, A, Kaleebu, P

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. by Wallis, C, Papathanasopoulos, M, Lakhi, S, Karita, E, Kamali, A, Kaleebu, P, Sanders, E, Anzala, O, Bekker, L, Stevens, G, de Wit, T, Stevens, W

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections by Grosskurth H, Kamali A, Maher D, Levin J, Vanham G, Balla S, Montefiori D, Sokolik-Wolak B, Tomusange K, Njai HF, Pala P, Kaleebu P

Comparison of sexual behavior and HIV risk between two HIV-1 serodiscordant couple cohorts: the CHAVI 002 study. by Ritchie, A, Kuldanek, K, Moodie, Z, Wang, Z, Fox, J, Nsubuga, R, Legg, K, Birabwa, E, Kaleebu, P, Mcmichael, A, Watera, C, Goonetilleke, N, Fidler, S

International health research monitoring: exploring a scientific and a cooperative approach using participatory action research. by Chantler, T, Cheah, P, Miiro, G, Hantrakum, V, Nanvubya, A, Ayuo, E, Kivaya, E, Kidola, J, Kaleebu, P, Parker, M, Njuguna, P, Ashley, E, Guerin, P, Lang, T